Abstract
These highlights focus on the research in lung transplantation (LTX) that has been published in the year 2022 and includes the assessment and optimization of candidates for LTX, donor optimization, the use of organs from donation after circulatory death (DCD), and outcomes when using marginal or novel donors, recipient factors affecting LTX, including age, disease, the use of extracorporeal life support (ECLS), and special situations, such as COVID-19, pediatric LTX, and retransplantation. The remainder of the article focuses on the perioperative management of LTX, including the perioperative risk factors for acute renal failure (AKI), and the incidence and management of phrenic nerve injury, delirium, and pain and the postoperative management of hyperammonemia, early postoperative infections, and the use of donor-derived cell-free deoxynucleic acid (DNA) to detect rejection.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
